Dr. Michael Attanasio, D.O

NPI: 1174593958
Total Payments
$263,805
2024 Payments
$25,238
Companies
73
Transactions
1,982
Medicare Patients
6,351
Medicare Billing
$711,176

Payment Breakdown by Category

Other$150,495 (57.0%)
Consulting$62,410 (23.7%)
Food & Beverage$34,351 (13.0%)
Travel$16,257 (6.2%)
Education$292.56 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $150,495 100 57.0%
Consulting Fee $62,410 30 23.7%
Food and Beverage $34,351 1,779 13.0%
Travel and Lodging $16,257 60 6.2%
Education $292.56 13 0.1%

Top Paying Companies

Company Total Records Latest Year
Janssen Pharmaceuticals, Inc $145,440 277 $0 (2024)
Amgen Inc. $59,184 145 $0 (2024)
ABBVIE INC. $18,449 202 $0 (2024)
Allergan, Inc. $12,738 66 $0 (2022)
AstraZeneca Pharmaceuticals LP $3,715 129 $0 (2024)
Novo Nordisk Inc $3,171 185 $0 (2024)
Takeda Pharmaceuticals America, Inc. $3,066 7 $0 (2017)
Eli Lilly and Company $2,250 1 $0 (2020)
GlaxoSmithKline, LLC. $1,940 111 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $1,750 98 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $25,238 258 Amgen Inc. ($12,316)
2023 $62,236 348 Amgen Inc. ($30,898)
2022 $42,402 303 Janssen Pharmaceuticals, Inc ($21,318)
2021 $29,384 216 Janssen Pharmaceuticals, Inc ($19,617)
2020 $22,474 206 Janssen Pharmaceuticals, Inc ($11,687)
2019 $14,101 188 Janssen Pharmaceuticals, Inc ($11,027)
2018 $32,535 237 Janssen Pharmaceuticals, Inc ($24,097)
2017 $35,435 226 Janssen Pharmaceuticals, Inc ($29,830)

All Payment Transactions

1,982 individual payment records from CMS Open Payments — Page 2 of 80

Date Company Product Nature Form Amount Type
11/14/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $17.33 General
Category: RESPIRATORY
11/12/2024 Kowa Pharmaceuticals America, Inc. ZORYVE (Drug) Food and Beverage In-kind items and services $16.56 General
Category: DERMATOLOGY
11/12/2024 Lilly USA, LLC MOUNJARO (Drug), ZEPBOUND Food and Beverage In-kind items and services $12.56 General
Category: Diabetes
11/05/2024 Novo Nordisk Inc Food and Beverage In-kind items and services $14.08 General
11/04/2024 ABBVIE INC. UBRELVY (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,000.00 General
Category: NEUROSCIENCE
11/04/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $10.89 General
Category: NEUROSCIENCE
11/02/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $13.79 General
Category: GASTROENTEROLOGY
11/01/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $20.03 General
Category: Cardiovascular and Metabolism
11/01/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $17.17 General
Category: Cardiology/Vascular Diseases
10/31/2024 Agios Pharmaceuticals, Inc. PYRUKYND (Drug) Food and Beverage In-kind items and services $29.21 General
Category: Genetically Defined Disease
10/29/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $17.54 General
Category: Cardio-renal
10/28/2024 Collegium Pharmaceutical, Inc. Belbuca (Drug) Food and Beverage Cash or cash equivalent $16.08 General
Category: Opioid Analgesic
10/25/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $14.06 General
Category: Inflammation
10/24/2024 SHIELD THERAPEUTICS INC ACCRUFER (Drug) Food and Beverage In-kind items and services $23.39 General
Category: Hematology
10/22/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug), SYNJARDY Food and Beverage In-kind items and services $18.17 General
Category: DIABETES
10/21/2024 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $28.21 General
Category: NEUROSCIENCE
10/18/2024 Xeris Pharmaceuticals, Inc. GVOKE HYPOPEN (Drug) Food and Beverage In-kind items and services $14.49 General
Category: Diabetes
10/17/2024 Novo Nordisk Inc Food and Beverage In-kind items and services $12.96 General
10/16/2024 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $24.21 General
Category: NEUROSCIENCE
10/15/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $19.19 General
Category: Inflammation
10/15/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $12.61 General
Category: NEUROSCIENCE
10/10/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $19.23 General
Category: RESPIRATORY
10/09/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC RELISTOR (Drug), RELISTOR Food and Beverage In-kind items and services $6.42 General
Category: Gastroenterology
10/08/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $10.89 General
Category: NEUROSCIENCE
10/07/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $14.42 General
Category: GASTROENTEROLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 11 1,238 2,124 $281,405 $103,488
2022 12 1,568 2,729 $385,415 $128,719
2021 13 1,832 3,628 $461,360 $277,409
2020 21 1,713 3,094 $384,335 $201,560
Total Patients
6,351
Total Services
11,575
Medicare Billing
$711,176
Procedure Codes
57

All Medicare Procedures & Services

57 procedure records from CMS Medicare Utilization — Page 3 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 16 17 $1,870 $1,057 56.5%
G0180 Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem Office 2020 21 21 $2,100 $980.70 46.7%
96372 Injection beneath the skin or into muscle for therapy, diagnosis, or prevention Office 2020 17 50 $1,750 $576.28 32.9%
G0008 Administration of influenza virus vaccine Office 2020 20 20 $700.00 $356.72 51.0%
93000 Routine ekg using at least 12 leads including interpretation and report Office 2020 22 22 $1,650 $314.64 19.1%
G0009 Administration of pneumococcal vaccine Office 2020 11 11 $385.00 $178.00 46.2%
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg Office 2020 12 44 $440.00 $66.59 15.1%

About Dr. Michael Attanasio, D.O

Dr. Michael Attanasio, D.O is a Family Medicine healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174593958.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Attanasio, D.O has received a total of $263,805 in payments from pharmaceutical and medical device companies, with $25,238 received in 2024. These payments were reported across 1,982 transactions from 73 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($150,495).

As a Medicare-enrolled provider, Attanasio has provided services to 6,351 Medicare beneficiaries, totaling 11,575 services with total Medicare billing of $711,176. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Other Specialties Family Medicine
  • Location Philadelphia, PA
  • Active Since 01/25/2006
  • Last Updated 12/27/2016
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • NPI Number 1174593958

Products in Payments

  • XARELTO (Drug) $88,517
  • Repatha (Biological) $58,259
  • INVOKANA (Drug) $56,923
  • UBRELVY (Drug) $18,645
  • VRAYLAR (Drug) $6,981
  • QULIPTA (Drug) $4,968
  • JARDIANCE (Drug) $3,377
  • Trintellix (Drug) $3,177
  • Ozempic (Drug) $1,610
  • TRELEGY ELLIPTA (Drug) $1,426
  • FARXIGA (Drug) $1,390
  • TRULICITY (Drug) $915.48
  • Kerendia (Drug) $860.21
  • BREZTRI (Drug) $851.93
  • ENTRESTO (Drug) $760.82
  • Vascepa (Drug) $712.58
  • XIFAXAN (Drug) $637.74
  • Otezla (Drug) $530.23
  • JANUVIA (Drug) $454.48
  • SYMBICORT (Drug) $430.51

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Philadelphia